Evidence map›Paper›PMID 41426031›Full record

ArticleKidney international reports2025

DMX-200 in Patients With Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial.

Hiddo J L Heerspink, Alessia Fornoni, Lesley A Inker, Irene L Noronha, Hernán Trimarchi, Muh Geot Wong, Alisha Smith, Robert Shepherd, Carl W White, David Fuller and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hiddo J L HeerspinkDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Alessia FornoniKatz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Lesley A InkerDivision of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
Irene L NoronhaLaboratory of Cellular, Genetic, and Molecular Nephrology, Division of Nephrology, University of São Paulo School of Medicine, São Paulo, Brazil.
Hernán TrimarchiNephrology Service, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Muh Geot WongFaculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Alisha SmithDimerix Bioscience, Fitzroy, Victoria, Australia.
Robert ShepherdDimerix Bioscience, Fitzroy, Victoria, Australia.
Carl W WhiteDimerix Bioscience, Fitzroy, Victoria, Australia.
David FullerDimerix Bioscience, Fitzroy, Victoria, Australia.
Jonathan BarrattUniversity of Leicester, Leicester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ARBAT1RCCR2DMX-200FSGSrepagermanium

Identifiers

PMID41426031
PMCPMC12712502

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.